Health
2nd study testing a COVID-19 antibody drug has a setback – Economic Times
Tests in animals suggest that antibody drugs work best when given early in infection to lower the amount of virus, he said. Once someone is very sick, the drugs…
For the second time, a study testing an experimental antibody drug for COVID-19 has been paused to investigate a possible safety issue in hospitalised patients.
Regeneron Pharmaceuticals Inc. said Friday that independent monitors had recommended placing on hold enrollment of the most severely ill patients — those who need intense oxygen treatment or breathing machines — because of a potential safety problem and unfavourable balance of risks and benefits.
The study can continue to test the two-antibody…
-
General15 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
Noosa News14 hours agoUnvaccinated horse dies from Hendra virus as Queensland records first case in three years
-
General23 hours agoDe Minaur to face Djokovic at Wimbledon, as Kasatkina bows out in straight sets
-
General17 hours agoBack-to-back rate cuts tipped when Reserve Bank meets